Company news

OpSens Inc news in 2021

OpSens Inc's news releases, calls and decks from 2021, newest first.

View company

OpSens announces 510(k) submission to U.S. FDA for new guidewire for the TAVR procedure

December 13, 2021

Opsens to Present at the Lytham Partners Winter 2021 Investor Conference: Presentation at 11 Am (ET), Monday December 13, 2021

December 7, 2021

OpSens Announces Fourth Quarter And Fiscal Year 2021 Financial Results

November 23, 2021

OpSens Successfully Completes 20-Patient in Human Clinical Study for TAVR Procedure

November 23, 2021

OpSens to Host Fourth Quarter Fiscal Year 2021 Financial Results Conference Call and Year-End Update on Tuesday, November 23, 2021

November 17, 2021

OpSens will Participate at Stifel 2021 Virtual Healthcare Conference and Canaccord Genuity MedTech & Diagnostics Forum

November 10, 2021

OPSENS' SAVVYWIRE(TM) Featured at the Transcatheter Cardiovascular Therapeutics 2021 Annual Meeting in Orlando

November 8, 2021

OpSens Successfully Treats First Patients in Human Clinical Study for TAVR Procedure

October 13, 2021

OpSens to Present at the Lytham Partners Fall 2021 Investor Conference

September 29, 2021

OPSENS Receives Approval from Health Canada to Initiate First In-Man Clinical Study for its New Guidewire for the TAVR Procedure

September 20, 2021

OpSens Appoints Lori Chmura to its Board of Directors

September 8, 2021

OpSens Announces Third Quarter Fiscal 2021 Record Financial Results

July 13, 2021

OpSens to Host Third Quarter Fiscal Year 2021 Financial Results Conference Call on Tuesday, July 13, 2021

July 7, 2021

OpSens Solutions Receives Funding Support to Jointly Develop an Optical-Based Fuel Monitoring System for Aerospace Applications, Including Civil Aircrafts

June 16, 2021

OpSens will Participate and Present at two Investment Conferences - Lytham Partners and Raymond James

June 9, 2021

OpSens to Participate in Virtual Fireside Chat at the 2021 RBC Capital Markets Global Healthcare Conference

May 13, 2021

OpSens Integrates its OptoWire's dPR and FFR Algorithms Within Cathmedical Cardiovascular's Picasso System in Spain

April 21, 2021

OpSens Announces Second Quarter Fiscal 2021 Financial Results and Record FFR and dPR Revenues

April 14, 2021

OpSens Awarded Innovative Technology Contract by Vizient for OptoWire III

April 7, 2021

OpSens to Host Second Quarter Fiscal Year 2021 Financial Results Conference Call on Wednesday, April 14, 2021

April 6, 2021

OpSens to Present at Lytham Partners Spring 2021 Investor Conference

March 22, 2021

OpSens Announces Closing of $28.75 Million Bought Deal Public Offering Including $3.75 Million Over-Allotment Option Exercised in Full

February 25, 2021

OpSens Obtains CE Marking for the OptoWire III

February 18, 2021

OpSens Solutions Fiber Optic Sensing Technology Selected for the International Thermonuclear Experimental Reactor (ITER)

February 8, 2021

OpSens Inc. Announces $25 Million Bought Deal Offering

February 5, 2021

OpSens Announces First Quarter Fiscal 2021 Financial Results

January 13, 2021

OpSens to Host First Quarter Fiscal Year 2021 Financial Results Conference Call on Wednesday, January 13, 2021

January 6, 2021

Decks in 2021